Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded encouraging discoveries into new therapeutic approaches. Current focus centers on modifying the underlying mechanisms of MSA. One approach under investigation involves drug-based interventions to regulate the function